Overview
- 10 inspections across 10 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-03-29.
At a glance
Inspections
10
Sites
10
Observations
0
Career since
Mar 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shenzhen Lantern Science Co., Ltd. | 29 Mar 2024 | Human Drugs | On file |
| Sunshine Lake Pharma Co., Ltd. | 22 Mar 2024 | Human Drugs | On file |
| Guangdong Blue Treasure Pharmaceuticals Co. Ltd. | 15 Mar 2024 | Human Drugs | |
| BSP Pharmaceuticals SpA | 21 Sep 2018 | Human Drugs | On file |
| Biogen U.S. Corporation | 4 May 2018 | Human Drugs | On file |
Sites inspected
Shenzhen Lantern Science Co., Ltd.Shenzhen, China1 insp.
Sunshine Lake Pharma Co., Ltd.Dongguan, China1 insp.
Guangdong Blue Treasure Pharmaceuticals Co. Ltd.Qingyuan, China1 insp.
BSP Pharmaceuticals SpALatina, Italy1 insp.
Biogen U.S. CorporationDurham, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Tekalign Wondimu3 shared
Jessica Hankins2 shared
Zhihao Pete Qiu2 shared
Viviana Matta1 shared
Reyes Candau-Chacon1 shared
Marion Michaelis1 shared
Maria I Cruz-Fisher1 shared
Monica M Commerford1 shared
Kristin M Abaonza1 shared
Diane L Raccasi1 shared
Full investigator report
Get the verbatim findings behind Ephrem T Hunde's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site